-

Hagens Berman: Lawsuit Accuses Amazon of Price-Gouging During COVID Pandemic

Law firm says consumer-rights class action lawsuit vs. Amazon now includes all U.S. shoppers

SEATTLE--(BUSINESS WIRE)--A class-action lawsuit accusing Amazon of price-gouging during the COVID-19 pandemic has now been expanded to include a proposed class of all Amazon shoppers nationwide who purchased affected products, according to law firm Hagens Berman.

The expanded lawsuit, filed July 2, 2021, accuses the world’s largest online retailer, Amazon.com, of engaging in “unconscionable” and unlawful price increases during the COVID-19 pandemic, inflating prices for essential goods by upwards of 1,800 percent.

If you purchased any consumer food items or goods, emergency supplies or medical products from Amazon during the COVID-19 crisis, find out more about the lawsuit and your rights.

The lawsuit against Amazon seeks repayment to consumers for Amazon’s price-gouging, and treble damages, as well as injunctive relief from the court barring Amazon’s overpricing, which attorneys say is illegal under state consumer-protection laws.

“Attempting to profit from a deadly pandemic is far from a victimless act,” said Steve Berman, managing partner of Seattle-based Hagens Berman. “When Amazon chose to hike up prices of emergency supplies and other goods while the world was reeling from COVID-19, it unlawfully price-gouged vulnerable consumers who were relying on Amazon to obtain goods safely.

“We intend to hold Amazon accountable for the choice it made.”

Price Fixed: Face Masks, Medicine, Toilet Paper, Food Staples & More

As the COVID-19 crisis escalated, so too have Amazon’s prices for goods consumers require to remain healthy, protected and nourished, attorneys say.

According to the lawsuit, “Amazon’s sales have never been higher, and since the COVID-19 pandemic began, its sales in some categories (e.g., home items) are up more than 1000 percent.” Meanwhile, Jeff Bezos’s personal wealth increased by $75 billion (or approximately $205 million per day) in 2020, during which hundreds of thousands of Americans lost their source of income and their lives to COVID-19.

After federal officials declared a public health emergency, certain Amazon prices increased as follows according to Hagens Berman’s filing:

  • Face Masks: Increases up to 1,800 percent, from $4.21 to $79.99;
  • Cold Remedies: Increases up to 1,523 percent, from $4.65 to $79.00;
  • Toilet Paper: Increases up to 1,044 percent, from $17.48 to $200;
  • Black Beans: Increases up to 521 percent, from $3.54 to $21.99;
  • Flour: Increases up to 400 percent, from $22.00 to $110.00;
  • Disinfectant Wipes: Increases of more than 745 percent, from $20.71 to $174.96.

All of these (and many more) Amazon price increases are flagrantly unlawful under Washington law, attorneys say.

Find out more about the class-action lawsuit against Amazon for price-gouging during the COVID-19 outbreak.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP is a consumer-rights class-action law firm operating in 10 cities worldwide. The firm’s tenacious drive for plaintiffs’ rights has earned it numerous national accolades, awards and titles of “Most Feared Plaintiff’s Firm,” MVPs and Trailblazers of class-action law. More about the law firm and its successes can be found at www.hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9363

Hagens Berman Sobol Shapiro LLP

NASDAQ:AMZN

Release Summary
A class-action lawsuit accusing Amazon price-gouging during the pandemic has been expanded to include all U.S. Amazon shoppers, says Hagens Berman.
Release Versions
$Cashtags

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9363

More News From Hagens Berman Sobol Shapiro LLP

Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman, a national shareholder rights law firm, is investigating whether Corcept Therapeutics Inc. (NASDAQ: CORT) misled investors about relacorilant’s efficacy and commercial prospects. Corcept is under renewed scrutiny after Reuters reported on Jan. 30, 2026, that the FDA had warned the company “on several occasions” not to submit its application for relacorilant, its proposed treatment for hypercortisolism. The report sent Corcept shares down, wiping ou...

Hagens Berman: Homebuyers Sue Rocket Mortgage and Affiliated Companies in Class Action Alleging Illegal Practices Inflating Home Prices

DETROIT--(BUSINESS WIRE)--A class-action lawsuit alleges homebuyers were illegally steered to use Rocket Mortgage, to their detriment, according to attorneys at Hagens Berman....

CoreWeave (CRWV) Faces Securities Class Action Over Denton Data Center Completion Delays, $14 Billion Market Cap Loss - Hagens Berman Investigates

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman, a national shareholder rights firm, announces a securities class-action lawsuit against CoreWeave, Inc. (NASDAQ: CRWV) and several executives on behalf of investors who purchased CoreWeave securities between March 28 and Dec. 15, 2025. The lawsuit alleges that CoreWeave misled investors about delays in its Denton, Texas data center cluster, intended to support OpenAI operations. Hagens Berman is reviewing whether CoreWeave’s statements about its re...
Back to Newsroom